Bio-En Holdings Corp carries a market capitalization of 170,170.00, placing it among publicly traded companies globally.
| Market Cap | 170,170.00 |
| Enterprise Value | N/A |
Bio-En Holdings Corp currently has 77.35M shares outstanding.
| Shares Outstanding | 77.35M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -70.19 |
| P/TBV Ratio | -116.98 |
| P/FCF Ratio | -2,523.45 |
| P/OCF Ratio | -2,523.45 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -541.40 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
EBITDA reached -77,921.00, while operating income came in at -77,921.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -77,921.00 |
| Pretax Income | -75,471.00 |
| Net Income | -75,471.00 |
| EBITDA | -77,921.00 |
| EBIT | -77,921.00 |
| Earnings Per Share (EPS) | 0.00 |
Total book value stands at -881,649.00, with working capital of -528,968.00 providing operational flexibility.
| Cash & Cash Equivalents | 1,679.00 |
| Total Debt | N/A |
| Net Debt | 385,571.00 |
| Equity (Book Value) | -881,649.00 |
| Book Value Per Share | -0.01 |
| Working Capital | -528,968.00 |
Bio-En Holdings Corp produced -24,522.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -24,522.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -24,522.00 |
| FCF Per Share | 0.00 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | N/A |
| FCF Yield | -0.04 |
Bio-En Holdings Corp posts an Altman Z-Score of -1,202.84, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1,202.84 |